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NecrosisA B S T R A C T
Tuberculosis is one of the leading causes of death byMycobacterium tuberculosis (Mtb) affect-
ing millions of people worldwide. Mycobacterium species enter host macrophages during
infection and target various cellular organelles and their function for their own benefit.
Mitochondria appear to be among the important targets for bacterial pathogens. Mtb and
other pathogenic bacteria secrete various proteins that initiate structural changes in mito-
chondria to modulate its function. Additionally, virulent mycobacteria interfere with the
balance between pro- and anti-apoptotic factors to inhibit apoptosis and, in later stages,
promote necrosis. Furthermore, mitochondria perform multiple biological functions in
the cell, and the inhibition of these functions by bacterial proteins promotes Mtb survival,
growth, and successful infection.
 2016 Asian-African Society for Mycobacteriology. Production and hosting by Elsevier Ltd.
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Tuberculosis (TB) caused by Mycobacterium tuberculosis (Mtb)
continues to be a major cause of morbidity and mortality
throughout the world. Despite the availability of various
effective drugs and Bacillus Calmette–Gue´rin (BCG) vaccines,
TB-control programs have failed to reduce this problem in
most parts of theworld. In 2013, it was estimated that approx-
imately one-third of the world population was asymptomati-
cally infected with Mtb, of which nine million people
developed TB and 1.5 million died from this deadly disease,
including one-fourth who were human immunodeficiency
virus (HIV)-positive [1]. Emergence of new resistant strains,
such as multidrug-resistant and extensively drug-resistant
strains, as well as other complicating factors, such as HIV
coinfection, has posed an extra burden on TB-control pro-
grams [2]. Therefore, there is an urgent need to find new
mycobacterial targets to allow for the development of drugs
against this deadly disease.
Mtb is the causal organism of TB that engulfs host macro-
phages through various available phagocytic receptors, of
which the complement of mannose receptors are the most
prevalent [3,4]. Virulent Mtb has adapted itself to enable its
survival in the host macrophage by utilizing various strate-
gies, such as preventing the fusion of phagosomes with lyso-
somes, restriction to phagosomal acidification, and targeting
cellular organelles, such as mitochondria, to disturb the bal-
ance of pro- and anti-apoptotic factors in order to escape
the immune response [5]. Mitochondria are double-
membrane-bound organelles that have evolved from an
endosymbiotic proteobacterium and perform various biologi-
cal functions, such as adenosine triphosphate (ATP) synthe-
sis, ion homeostasis, biosynthesis of fatty acids, calcium
storage, iron-sulfur-cluster biogenesis, and regulation of
cell-death pathways. Due to the multiple and diverse roles
of mitochondria, it is an attractive target organelle for bacte-
rial pathogens. Therefore, one could hypothesize that inter-
ference with mitochondrial functions would be useful to
pathogens for establishment of successful infection.
Mtb and apoptosis
Apoptosis is an evolutionarily preserved mechanism for cell
self-destruction, and it plays an important role in many phys-
iological processes, such as morphogenetic changes in
embryonic development, aging, and homeostatic mainte-
nance [6]. Most pathological conditions are linked to the mis-
regulation of programmed cell death, with examples
involving neurodegenerative diseases, cardiovascular dis-
eases, cancers, and acquired immune deficiency syndrome
[7,8]. Apoptosis induction in response to viral infection is also
well established. Many viral pathogens are known to encode
genes whose products inhibit host cell death to provide a suit-
able niche for viral replication and survival [9,10]. Apoptosis is
an innate cellular defense mechanism that is usually initiated
under stress conditions. Pathogenic bacteria have evolved
various strategies to target host cells to either to inhibit
apoptosis for their survival and growth or promote apoptosis.
Virulent strains of Mtb inhibit apoptosis in macrophagesthrough upregulation of antiapoptotic proteins, such as
B-cell lymphoma (Bcl)-2 and Mcl-1, through destruction of
mitochondrial transmembrane potential and by depletion of
cytochrome c [11–13].
In addition to Mtb, other pathogenic bacteria of the
mycobacterium species include Mycobacterium leprae, which
causes leprosy and induces apoptosis through upregulation
of Mcl-1 expression and downregulation of the Bcl-2-
associated death promoter and Bcl-2 homologous antago-
nist/killer (Bak) proteins [12], wild-type Mycobacterium bovis,
which induces low levels of apoptosis by increasing produc-
tion of interleukin-10 and Bcl-2 and reduces production of
tumor necrosis factor (TNF)-a [14]. TNF-a production is critical
for the induction of apoptosis in mycobacteria-infected
macrophages [15]. Other bacteria known to induce apoptosis
include Pseudomonas aeruginosa, Escherichia coli, Listeria
monocytogenes, Neisseriae spp., Yersinia pseudotuberculosis,
Yersinia pestis, Yersinia enterocolitica, Salmonella typhimurium,
and Shigella Flexneri [16].
Mtb infection predominantly leads to necrosis, a form of
cell death characterized by plasma-membrane disruption
that differs from apoptosis, where the integrity of the plasma
membrane is preserved. Mtb induces necrosis to evade host
defenses and to exit macrophages in order to disseminate
to and infect surrounding cells. H37Rv, a pathogenic strain
of mycobacterium, promotes necrosis by inducing substantial
alterations to mitochondrial transmembrane potential [17]. A
recent study reported that Mtb PPE68 and Rv2626c genes
encoded proteins involved in aiding bacterial escape from
host macrophages by promoting necrosis. Deletion of the
Rv2626c gene resulted in decreased necrosis induction, while
overexpression promoted significant necrosis [18]. However,
there is limited information available regarding the mecha-
nism used by bacteria to promote necrosis.
Mitochondrial roles in induction of apoptosis and
necrosis
Mitochondrion plays a key role in the regulation of apoptotic
cell death [8]. These organelles are not only involved in intrin-
sic cell-death pathways, but they are also involved in extrinsic
cell-death pathways in some cell types. Intrinsic
mitochondria-mediated cell death differs from extrinsic
cell-death pathways in how it is elicited in the presence of
various stressors associated with the intracellular environ-
ment, such as DNA damage, microbial infection, and oxida-
tive stress. In contrast, the extrinsic pathway is initiated by
extracellular cell-death signals. In response to specific apop-
totic stimuli, mitochondria release the proapoptotic factor
cytochrome c and apoptosis inducing factor (AIF).
Cytochrome c associates with a scaffold protein, apoptotic
protease activating factor-1, to drive the assembly of a
supramolecular complex known as the apoptosome, which
leads to the activation of caspase cascades that lead to cell
death [19]. X-linked inhibitor of apoptosis protein possesses
caspase-inhibitory activity, which is counteracted by second
mitochondria-derived activator of caspase/direct inhibitor of
apoptosis-binding protein, a mitochondrion-derived activator

































Fig. 1 – Mitochondrial behavior in response to pathogenic and nonpathogenic mycobacteria. (1) Pathogenic mycobacteria
modulate cell-death pathways by inhibiting or promoting apoptosis through multiple mechanisms, including regulating
expression of antiapoptotic and proapoptotic proteins. Most virulent mycobacteria downregulate proapoptotic genes and
upregulate antiapoptotic genes to promote apoptosis, while avirulent species promote upregulation of proapoptotic genes
and downregulation of antiapoptotic genes. (2) Pathogenic mycobacteria may affect the outer membrane of mitochondria,
causing mitochondrial outer-membrane permeabilization (MOMP) and release of cytochrome c from the intermembrane
space to the cytosol, thereby activating caspases and leading to apoptosis. This pathway is also utilized by several
nonpathogenic mycobacteria to initiate apoptosis. Pathogenic mycobacteria are also capable of affecting the inner membrane
of mitochondria, which alters the mitochondrial permeability transition pore complex (mPTPC) and leads to necrosis. (3)
Generation of mitochondrial reactive oxygen species in conjunction with excessive tumor necrosis factor activation upon
pathogenic mycobacteria infection alters the mPTPC and promotes necrosis. Reactive oxygen species (ROS) is also capable of
inducing autophagy to promote acidification of phagosomes containing bacteria and phagolysosomal fusion. (4) In order for
pathogenic mycobacteria to evade host defenses, they also inhibit autophagy, phagosome acidification and phagolysosomal
fusion, while nonpathogenic mycobacteria inhibit phagosome acidification and phagolysosomal fusion, and induce
autophagy. Inhibitors of apoptosis protein(s) (IAP) = ; TNF = tumor necrosis factor.
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translocation to the nucleus and induction of DNA degrada-
tion [21,22]. Bcl-2-family members include pro- and anti-
apoptotic proteins that regulate mitochondrial outer
membrane permeabilization [23]. Antiapoptotic proteins,
such as Bcl-2 or Bcl-extra-large and other members, prevent
apoptosis, whereas proapoptotic proteins, such as Bcl-2-like
protein 11, Bcl-2-associated X Protein, or Bak, promote apop-
tosis [24]. Besides apoptosis, necrosis is also a form of cell
death that is uncontrolled or pathological. Early alteration
of the mitochondrial permeability transition pore in the inner
membrane of mitochondria is a key event in primary necrosis
that occurs in the absence of cytochrome c release. Opening
of this pore leads to the loss of the proton gradient and a ces-
sation of ATP generation through oxidative phosphorylation
and massive inflow of water into the solute-rich matrix,
resulting in severe swelling of the mitochondrion. While pore
opening releases apoptogenic factors that initiate apoptosis,
persistent opening of pores leads to necrotic cell death [25,26].Mitochondrial autophagy
Mitochondrial autophagy or mitophagy is the selective elimi-
nation of damaged mitochondria in order to maintain home-
ostasis and regulate mitochondrial load to balance the
biological and metabolic demands of the cell [27,28]. It pre-
vents the fusion of damaged mitochondria with healthy mito-
chondria to contribute to the maintenance of healthy
mitochondrial networks [29]. Damaged mitochondrion can
induce apoptosis through the release of cytochrome c and cal-
cium [30]. Phosphatase and tensin homolog-induced putative
kinase 1 (PINK1) and the ubiquitin ligase Parkin regulate mito-
phagy. In normal cases, PINK1 is imported into mitochondria,
where its N-terminal mitochondria-targeting sequence is pro-
cessed in the matrix, and the kinase is degraded by cytosolic
and mitochondrial proteases [31]. In cases of severe depletion
of mitochondrial inner-membrane potential, PINK1 import
leads to its accumulation in the outer-mitochondrial mem-
brane (OMM) and recruitment of Parkin from the cytosol.
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ligase activity to enable OMM protein polyubiquitination.
Parkin is able to ubiquitinate various proteins available on
the OMM and in the cytosol to facilitate the recruitment of
autophagy machinery for degradation of defective mitochon-
dria [32].
Recent studies demonstrated the role of Parkin in
ubiquitin-mediated Mtb autophagy. Parkin protein, a ubiqui-
tin ligase, mediates resistance to intracellular pathogens,
and deletion of this gene is associated with increased suscep-
tibility to such intracellular pathogens in humans. In cases of
defective Parkin, Mtb proliferation increases in macrophages
[33]. A recent finding observed that virulent Mtb after macro-
phage infection affects mitochondria in a number of ways,
including mitochondria distribution, size, number, and frag-
mentation, while nonpathogenic strains of mycobacteria,
such as M. bovis BCG, were unable to elicit the same effect
[34]. Similar patterns of mitochondrial disruption and net-
work fragmentation were observed in L. monocytogenes-
infected epithelial cells [35].
Mitochondria targeted by bacterial proteins
To exert effects on mitochondrial function, bacterial proteins
must bind to and be taken up by mitochondria during infec-
tion [36]. Various pathogenic bacterial proteins interact with
host mitochondria and determine the fate of the cell by
affecting processes, such as inhibition of apoptosis and
necrosis. Some bacterial porins that form b-barrel structures
in the outer membrane of Gram negative bacteria can induce
cell death by targeting mitochondria [37]. Acinetobacter bau-
mannii Omp38 targets mitochondria to induce the formation
of channels for the release of cytochrome c, which promotes
apoptosis [38]. Neisseria gonorrhoeae PorB induces apoptosis,
while the homolog from Neisseria meningitidis inhibits host-
cell apoptosis during infection [39]. Pneumolysin, a bacterial
toxin secreted by Staphylococcus aureus and vacuolating cyto-
toxin, a virulent factor of Helicobacter pylori, were reported to
modulate host-cell mitochondria and, in turn, induce apopto-
sis [40]. Bioinformatics studies ofMycobacterium avium (subsp.
Paratuberculosis) andMtb, causative agents of Johne’s disease
and tuberculosis, respectively, confirmed that somemycobac-
terial proteins target the mitochondria [41,42]; however, no
experimental evidence currently exists.Conclusion
Virulence factors are mainly involved in the interaction of
mycobacteria with host macrophages (Fig. 1). Few of these
factors are implicated in the adaptation of the bacilli inside
the macrophage to limited nutritional conditions. The factors
include proteins required for the uptake of nutrients and ions,
as well as metabolic switching that occurs when mycobacte-
ria is inside host cells. Proteins that participate in the
mechanisms triggered by mycobacteria offset microbicidal
host-cell responses, such as: (1) arresting the encounter of
the phagosome and enhancing resistance to host toxic com-
ponents (cell-wall barriers and specific effectors); (2) escapingfrom the intracellular compartment; and (3) avoiding the
development of localized and productive immune responses.
In these physiological events, the mitochondrion is an impor-
tant host target for pathogenic bacteria due to its multiple
roles in programmed cell death, cellular metabolism, and
the innate-immune system. Mitochondria are dynamic orga-
nelles that play defensive roles against many bacterial patho-
gens; however, many bacteria have evolved to utilize multiple
self-defense mechanisms. Various bacterial pathogens pro-
duce pathogenicity factors that participate in the modulation
of mitochondrial functions that ultimately decide the fate of
the host cell. Knowledge of mycobacterial proteins and the
precise mechanisms by which they interact with important
host organelles, including mitochondria, to affect their func-
tion will provide better understanding of mycobacterial
pathogenesis.
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